Published in Mol Vis on April 15, 2011
Relationship between foveal cone specialization and pit morphology in albinism. Invest Ophthalmol Vis Sci (2014) 2.22
DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics. Hum Mutat (2013) 1.25
A novel nonsense mutation of the GPR143 gene identified in a Chinese pedigree with ocular albinism. PLoS One (2012) 0.90
Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1). PLoS One (2014) 0.88
Clinical Insights Into Foveal Morphology in Albinism. J Pediatr Ophthalmol Strabismus (2015) 0.80
GPR143 Gene Mutations in Five Chinese Families with X-linked Congenital Nystagmus. Sci Rep (2015) 0.76
Clinical evaluation and molecular screening of a large consecutive series of albino patients. J Hum Genet (2016) 0.76
Macular optical coherence tomography findings and GPR143 mutations in patients with ocular albinism. Int Ophthalmol (2014) 0.75
Retrospective analysis in oculocutaneous albinism patients for the 2.7 kb deletion in the OCA2 gene revealed a co-segregation of the controversial variant, p.R305W. Cell Biosci (2017) 0.75
A novel nonsense mutation in the tyrosinase gene is related to the albinism in a capuchin monkey (Sapajus apella). BMC Genet (2017) 0.75
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet (1995) 4.97
A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature (1993) 3.24
Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci (2006) 3.18
Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4. Am J Hum Genet (2001) 2.43
A three-single-nucleotide polymorphism haplotype in intron 1 of OCA2 explains most human eye-color variation. Am J Hum Genet (2006) 2.14
L-DOPA is an endogenous ligand for OA1. PLoS Biol (2008) 2.03
Molecular genetics of human pigmentation diversity. Hum Mol Genet (2009) 2.03
Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. N Engl J Med (1994) 1.98
Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome. Nat Genet (1995) 1.95
Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism. Hum Mol Genet (1995) 1.64
Organization and sequence of the human P gene and identification of a new family of transport proteins. Genomics (1995) 1.60
Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3". Am J Hum Genet (1996) 1.59
Identification of a novel GPR143 mutation in a large Chinese family with congenital nystagmus as the most prominent and consistent manifestation. J Hum Genet (2007) 1.42
A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients. Invest Ophthalmol Vis Sci (2008) 1.39
Functional variation of MC1R alleles from red-haired individuals. Hum Mol Genet (2001) 1.38
Deletion in the OA1 gene in a family with congenital X linked nystagmus. Br J Ophthalmol (2001) 1.32
Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma. Eur J Hum Genet (2005) 1.28
Retinal mitosis is regulated by dopa, a melanin precursor that may influence the time at which cells exit the cell cycle: analysis of patterns of cell production in pigmented and albino retinae. J Comp Neurol (1999) 1.18
Identification of a novel GPR143 deletion in a Chinese family with X-linked congenital nystagmus. Mol Vis (2008) 1.17
Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol Biomarkers Prev (2004) 1.15
P gene as an inherited biomarker of human eye color. Cancer Epidemiol Biomarkers Prev (2002) 1.15
A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism. Proc Natl Acad Sci U S A (1990) 1.14
Retinal cell addition and rod production depend on early stages of ocular melanin synthesis. J Comp Neurol (2000) 1.12
Genetic association and cellular function of MC1R variant alleles in human pigmentation. Ann N Y Acad Sci (2003) 1.09
Autosomal recessive ocular albinism associated with a functionally significant tyrosinase gene polymorphism. Nat Genet (1995) 1.08
Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis. Pigment Cell Res (2000) 1.07
X-linked ocular albinism in Blacks. Ocular albinism cum pigmento. Arch Ophthalmol (1978) 1.06
Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism. Invest Ophthalmol Vis Sci (2008) 1.05
The melanocortin-1 receptor: red hair and beyond. Arch Dermatol (2001) 1.03
Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa. Hum Mutat (2000) 1.01
VEP projections in congenital nystagmus; VEP asymmetry in albinism: a comparison study. Invest Ophthalmol Vis Sci (1991) 1.00
MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2). Am J Hum Genet (2003) 0.95
A novel GPR143 duplication mutation in a Chinese family with X-linked congenital nystagmus. Mol Vis (2009) 0.94
[Analysis of 180 patients with sensory defect nystagmus (SDN) and congenital idiopathic nystagmus (CIN)]. Klin Monbl Augenheilkd (2001) 0.87
The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism. Am J Med Genet A (2009) 0.86
Molecular basis of oculocutaneous albinism type 1 in Lebanese patients. J Hum Genet (2005) 0.84
Mutation analysis in a family with oculocutaneous albinism manifesting in the same generation of three branches. Mol Vis (2007) 0.84
A novel P gene missense mutation in a Japanese patient with oculocutaneous albinism type II (OCA2). J Dermatol Sci (2003) 0.81
Prenatal diagnosis of oculocutaneous albinism type II and novel mutations in two Chinese families. Prenat Diagn (2007) 0.81
Association of polymorphic sites in the OCA2 gene with eye colour using the tree scanning method. Ann Hum Genet (2007) 0.81
Initiation codon mutation of the tyrosinase gene as a cause of human albinism. Clin Chim Acta (1994) 0.78
CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia. Eur J Hum Genet (2005) 2.37
Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet (2005) 2.26
SOX2 anophthalmia syndrome. Am J Med Genet A (2005) 2.24
Genotyping microarray (disease chip) for Leber congenital amaurosis: detection of modifier alleles. Invest Ophthalmol Vis Sci (2005) 2.20
BIGH3 mutation spectrum in corneal dystrophies. Invest Ophthalmol Vis Sci (2002) 2.19
Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia. Am J Hum Genet (2002) 2.10
TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2009) 1.93
FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet (2003) 1.70
Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One (2013) 1.40
Novel mutations in FRMD7 in X-linked congenital nystagmus. Mutation in brief #963. Online. Hum Mutat (2007) 1.38
Disease-causing 7.4 kb cis-regulatory deletion disrupting conserved non-coding sequences and their interaction with the FOXL2 promotor: implications for mutation screening. PLoS Genet (2009) 1.32
Phenotypes of 16 Stargardt macular dystrophy/fundus flavimaculatus patients with known ABCA4 mutations and evaluation of genotype-phenotype correlation. Graefes Arch Clin Exp Ophthalmol (2002) 1.26
X-linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15. Invest Ophthalmol Vis Sci (2003) 1.25
Whole-exome sequencing identifies mutations in GPR179 leading to autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2012) 1.25
Identification and in vitro expression of novel CDH23 mutations of patients with Usher syndrome type 1D. Hum Mutat (2002) 1.25
Congenital cataract and macular hypoplasia in humans associated with a de novo mutation in CRYAA and compound heterozygous mutations in P. Graefes Arch Clin Exp Ophthalmol (2006) 1.23
Role of SOX2 mutations in human hippocampal malformations and epilepsy. Epilepsia (2006) 1.22
Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates. Mol Ther (2008) 1.20
Fundus autofluorescence in children and teenagers with hereditary retinal diseases. Graefes Arch Clin Exp Ophthalmol (2005) 1.19
Oculo-auriculo-vertebral spectrum (OAVS): clinical evaluation and severity scoring of 53 patients and proposal for a new classification. Eur J Med Genet (2005) 1.15
Genotyping microarray for CSNB-associated genes. Invest Ophthalmol Vis Sci (2009) 1.10
Large deletions of the KCNV2 gene are common in patients with cone dystrophy with supernormal rod response. Hum Mutat (2011) 1.06
Identification of novel mutations in X-linked retinitis pigmentosa families and implications for diagnostic testing. Mol Vis (2008) 1.05
Gene therapy for vision loss -- recent developments. Discov Med (2010) 1.04
Thirty distinct CACNA1F mutations in 33 families with incomplete type of XLCSNB and Cacna1f expression profiling in mouse retina. Eur J Hum Genet (2002) 1.03
Fundus autofluorescence in carriers of X-linked recessive retinitis pigmentosa associated with mutations in RPGR, and correlation with electrophysiological and psychophysical data. Graefes Arch Clin Exp Ophthalmol (2004) 1.01
Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy. Hum Mutat (2003) 0.99
Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations. Graefes Arch Clin Exp Ophthalmol (2004) 0.98
Bilateral tonic pupils with evidence of anti-hu antibodies as a paraneoplastic manifestation of small cell lung cancer. Ophthalmologica (2004) 0.97
Functional antibodies targeting IsaA of Staphylococcus aureus augment host immune response and open new perspectives for antibacterial therapy. Antimicrob Agents Chemother (2010) 0.96
Phenotypic variability in three carriers from a family with choroideremia and a frameshift mutation 1388delCCinsG in the REP-1 gene. Ophthalmic Genet (2003) 0.96
Novel causative mutations in patients with Nance-Horan syndrome and altered localization of the mutant NHS-A protein isoform. Mol Vis (2008) 0.92
Misrouting of the optic nerves in albinism: estimation of the extent with visual evoked potentials. Invest Ophthalmol Vis Sci (2005) 0.91
Unilateral adult malignant optic nerve glioma. Graefes Arch Clin Exp Ophthalmol (2004) 0.91
Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data. Ophthalmology (2009) 0.90
Disturbed visual system function in methionine synthase deficiency. Graefes Arch Clin Exp Ophthalmol (2004) 0.90
Superior oblique tucking with versus without additional inferior oblique recession for acquired trochlear nerve palsy. Graefes Arch Clin Exp Ophthalmol (2009) 0.89
Automated segmentation of pathological cavities in optical coherence tomography scans. Invest Ophthalmol Vis Sci (2013) 0.89
Fundus albipunctatus associated with compound heterozygous mutations in RPE65. Ophthalmology (2011) 0.89
Pediatric clinical visual electrophysiology: a survey of actual practice. Doc Ophthalmol (2006) 0.88
RPGR: role in the photoreceptor cilium, human retinal disease, and gene therapy. Ophthalmic Genet (2010) 0.88
Lack of autofluorescence in fundus albipunctatus associated with mutations in RDH5. Retina (2010) 0.88
Feasibility and outcome of automated kinetic perimetry in children. Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Automated segmentation of retinal blood vessels in spectral domain optical coherence tomography scans. Biomed Opt Express (2012) 0.87
Mosaic synaptopathy and functional defects in Cav1.4 heterozygous mice and human carriers of CSNB2. Hum Mol Genet (2013) 0.84
Mutation analysis in a family with oculocutaneous albinism manifesting in the same generation of three branches. Mol Vis (2007) 0.84
Comparison of central retinal thickness in healthy children and adults measured with the Heidelberg Spectralis OCT and the zeiss Stratus OCT 3. Ophthalmologica (2010) 0.84
Bestrophin 1--Phenotypes and Functional Aspects in Bestrophinopathies. Ophthalmic Genet (2015) 0.83
[On the effect of mutations of the fibroblast growth factor receptors as exemplified by three cases of craniosynostoses]. Klin Monbl Augenheilkd (2003) 0.83
Mutations in RD3 are associated with an extremely rare and severe form of early onset retinal dystrophy. Invest Ophthalmol Vis Sci (2012) 0.83
In vivo assessment of retinal vascular wall dimensions. Invest Ophthalmol Vis Sci (2010) 0.82
Evolution of central corneal thickness in children with congenital glaucoma requiring glaucoma surgery. Graefes Arch Clin Exp Ophthalmol (2007) 0.82
Long-term follow-up of the human phenotype in three siblings with cone dystrophy associated with a homozygous p.G461R mutation of KCNV2. Invest Ophthalmol Vis Sci (2011) 0.82
OCT-Based Macular Structure-Function Correlation in Dependence on Birth Weight and Gestational Age-the Giessen Long-Term ROP Study. Invest Ophthalmol Vis Sci (2016) 0.80
Age matters--thoughts on a grading system for ABCA4 mutations. Graefes Arch Clin Exp Ophthalmol (2004) 0.80
Heritability of strabismus: genetic influence is specific to eso-deviation and independent of refractive error. Twin Res Hum Genet (2012) 0.80
Interchangeability of macular thickness measurements between different volumetric protocols of Spectralis optical coherence tomography in normal eyes. Graefes Arch Clin Exp Ophthalmol (2011) 0.79
Fundus-controlled two-color dark adaptometry with the Microperimeter MP1. Graefes Arch Clin Exp Ophthalmol (2015) 0.79
Evidence of intrafamilial variability of CBFA1/RUNX2 expression in cleidocranial dysplasia--a family study. J Orofac Orthop (2002) 0.79
De novo double mutation in PAX6 and mtDNA tRNA(Lys) associated with atypical aniridia and mitochondrial disease. J Mol Med (Berl) (2006) 0.79
The effects of midazolam on intraocular pressure in children during examination under sedation. Br J Ophthalmol (2010) 0.79
Electron microscopic findings in levator muscle biopsies of patients with isolated congenital or acquired ptosis. Graefes Arch Clin Exp Ophthalmol (2007) 0.78
Analysis of three genes in Leber congenital amaurosis in Indonesian patients. Vision Res (2003) 0.78
Improving detection of mild loss of retinal light increment sensitivity at the posterior pole with the microperimeter MP1. Invest Ophthalmol Vis Sci (2013) 0.77
Prevalence and diagnostic spectrum of generalized retinal dystrophy in Danish children. Ophthalmic Epidemiol (2013) 0.76
Assessment of cortical visual field representations with multifocal VEPs in control subjects, patients with albinism, and female carriers of ocular albinism. Invest Ophthalmol Vis Sci (2006) 0.76
Normative values of peripheral retinal thickness measured with Spectralis OCT in healthy young adults. Graefes Arch Clin Exp Ophthalmol (2014) 0.75
Systematic review of digital imaging screening strategies for retinopathy of prematurity. Pediatrics (2009) 0.75
The Brückner transillumination test: limited detection of small-angle esotropia. Ophthalmology (2011) 0.75
Two patients with the heterozygous R189H mutation in ACTA2 and Complex congenital heart defects expands the cardiac phenotype of multisystemic smooth muscle dysfunction syndrome. Am J Med Genet A (2017) 0.75
In search for increased prevalence rates of strabismus and microstrabismus in two Bavarian districts, Oberpfalz and Niederbayern, to spot populations for gene identification. Strabismus (2002) 0.75
Shared decision-making, control preferences and psychological well-being in patients with RPE65 deficiency awaiting experimental gene therapy. Ophthalmic Res (2015) 0.75